Emcure Pharmaceuticals Limited (BOM:544210)

Market Cap	253.73B
Revenue (ttm)	78.96B
Net Income (ttm)	6.81B
Shares Out	n/a
EPS (ttm)	36.43
PE Ratio	37.24
Forward PE	27.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,773
Average Volume	16,692
Open	1,314.95
Previous Close	1,312.35
Day's Range	1,304.65 - 1,352.90
52-Week Range	890.00 - 1,577.50
Beta	n/a
RSI	51.33
Earnings Date	Aug 6, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 10,852
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544210

Financial Performance

In 2024, Emcure Pharmaceuticals's revenue was 78.96 billion, an increase of 18.59% compared to the previous year's 66.58 billion. Earnings were 6.81 billion, an increase of 36.76%.